Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-09-07 Sale |
2021-09-08 5:02 pm |
Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks |
1,000,000 | $4.3471 | $4,347,100 | 1,279,049 (Direct) |
View |
2021-09-07 Sale |
2021-09-07 4:09 pm |
Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer |
25,000 | $4.2442 | $106,105 | 11,065 (Direct) |
View |
2020-06-26 Purchase |
2020-06-30 8:07 pm |
Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer |
6,700 | $14.39 | $96,445 | 111,065 (Direct) |
View |
2020-06-25 Purchase |
2020-06-29 8:13 pm |
Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks 10% Owner |
7,000 | $14.48 | $101,356 | 2,279,049 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-05-12 Option Award |
2022-05-16 5:11 pm |
N/A 2032-05-12 |
Forte Biosciences Inc. | FBRX | Doberstein Stephen K Director |
50,000 | $0 | 50,000 (Direct) |
View |
2022-03-16 Option Award(A) |
2022-05-16 4:58 pm |
N/A 2023-03-16 |
Forte Biosciences Inc. | FBRX | FINCK BARBARA K Director |
4,166 | $0 | 4,166 (Direct) |
View |
2022-03-16 Option Award |
2022-03-18 5:23 pm |
N/A 2023-03-16 |
Forte Biosciences Inc. | FBRX | FINCK BARBARA K Director |
50,000 | $0 | 50,000 (Direct) |
View |
2022-02-23 Option Award |
2022-02-24 5:08 pm |
N/A 2032-02-23 |
Forte Biosciences Inc. | FBRX | Williams Donald Allen Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-02-23 Option Award |
2022-02-24 5:06 pm |
N/A 2032-02-23 |
Forte Biosciences Inc. | FBRX | Walker Patricia S Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-02-23 Option Award |
2022-02-24 5:04 pm |
N/A 2032-02-23 |
Forte Biosciences Inc. | FBRX | Kornfeld Steven Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-02-23 Option Award |
2022-02-24 5:02 pm |
N/A 2032-02-23 |
Forte Biosciences Inc. | FBRX | Eichenfield Lawrence Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-01-17 Option Award |
2022-01-18 8:39 pm |
N/A 2032-01-17 |
Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2022-01-17 Option Award |
2022-01-18 8:26 pm |
N/A 2032-01-17 |
Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks |
300,000 | $0 | 300,000 (Direct) |
View |
2021-05-28 Option Award |
2021-06-01 7:33 pm |
N/A 2031-05-28 |
Forte Biosciences Inc. | FBRX | Eichenfield Lawrence Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-05-28 Option Award |
2021-06-01 7:30 pm |
N/A 2031-05-28 |
Forte Biosciences Inc. | FBRX | Walker Patricia S Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-05-28 Option Award |
2021-06-01 7:29 pm |
N/A 2031-05-28 |
Forte Biosciences Inc. | FBRX | Williams Donald Allen Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-05-28 Option Award |
2021-06-01 7:25 pm |
N/A 2031-05-28 |
Forte Biosciences Inc. | FBRX | Kornfeld Steven Director |
20,000 | $0 | 20,000 (Direct) |
View |
2021-04-09 Option Award |
2021-04-13 6:04 pm |
N/A 2031-04-09 |
Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer |
42,500 | $0 | 42,500 (Direct) |
View |
2021-04-09 Option Award |
2021-04-13 6:03 pm |
N/A 2031-04-09 |
Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks 10% Owner |
175,000 | $0 | 175,000 (Direct) |
View |
2021-01-13 Exercise |
2021-01-14 7:17 pm |
N/A N/A |
Forte Biosciences Inc. | FBRX | DARCY THOMAS E Director |
500 | $9.5865 | 26,995 (Direct) |
View |
2021-01-13 Exercise |
2021-01-14 7:17 pm |
N/A 2021-06-15 |
Forte Biosciences Inc. | FBRX | DARCY THOMAS E Director |
500 | $0 | 26,995 (Direct) |
View |
2020-06-30 Option Award |
2020-06-30 8:07 pm |
N/A 2030-06-30 |
Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer |
75,000 | $0 | 111,065 (Direct) |
View |
2020-06-15 Option Award |
2020-06-17 8:56 pm |
N/A 2030-06-15 |
Forte Biosciences Inc. | FBRX | Williams Donald Allen Director |
30,000 | $0 | 30,000 (Direct) |
View |
2020-06-15 Option Award |
2020-06-17 8:55 pm |
N/A 2030-06-15 |
Forte Biosciences Inc. | FBRX | Kornfeld Steven Director |
30,000 | $0 | 30,000 (Direct) |
View |
2020-06-15 Option Award |
2020-06-17 8:54 pm |
N/A 2030-06-15 |
Forte Biosciences Inc. | FBRX | Eichenfield Lawrence Director |
30,000 | $0 | 30,000 (Direct) |
View |
2020-06-15 Option Award |
2020-06-17 8:52 pm |
N/A 2030-06-15 |
Forte Biosciences Inc. | FBRX | Walker Patricia S Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2020-06-17 4:51 pm |
N/A 2030-02-09 |
Forte Biosciences Inc. | FBRX | Walker Patricia S Director |
0 | $0 | 5,270 (Direct) |
View |
Ownership |
2020-06-17 4:50 pm |
N/A 2028-05-18 |
Forte Biosciences Inc. | FBRX | Eichenfield Lawrence Director |
0 | $0 | 21,081 (Direct) |
View |
Ownership |
2020-06-17 4:47 pm |
N/A N/A |
Forte Biosciences Inc. | FBRX | Riley Antony A Chief Financial Officer |
0 | $0 | 39,906 (Direct) |
View |
Ownership |
2020-06-17 4:38 pm |
N/A N/A |
Forte Biosciences Inc. | FBRX | Wagner Paul A. See Remarks |
0 | $0 | 2,693,702 (Direct) |
View |
2020-06-15 Option Award |
2020-06-15 5:34 pm |
N/A N/A |
Tocagen Inc | TOCA | DARCY THOMAS E Director |
1,858 | $0 | 26,495 (Direct) |
View |